Similar articles

• [Tumor markers in the diagnosis of pancreatic carcinoma].

  Lemma F, Bombardieri T, Salibra M, Trovato P, De Pasquale MC, Faraone V, Punturiero R, Di Mauro S. Lemma F, et al. Minerva Med. 1989 Jul;80(7):645-9. Minerva Med. 1989. PMID: 2779818 Italian. No abstract available.
• Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.

  Nishida K, Tasaki N, Miyagawa H, Yoshikawa T, Kondo M. Nishida K, et al. Am J Gastroenterol. 1988 Feb;83(2):126-9. Am J Gastroenterol. 1988. PMID: 3422536
• [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma].

  Fabris C, Basso D, Meggiato T, Del Favero G, Fogar P, Panozzo MP, Ferrara C, Scalon P, Naccarato R. Fabris C, et al. Recenti Prog Med. 1991 Mar;82(3):166-72. Recenti Prog Med. 1991. PMID: 2047559 Review. Italian.
• Serum markers and clinical data in diagnosing pancreatic cancer: a contrastive approach.

  Fabris C, Del Favero G, Basso D, Piccoli A, Meggiato T, Angonese C, Plebani M, Leandro G, Burlina A, Naccarato R. Fabris C, et al. Am J Gastroenterol. 1988 May;83(5):549-53. Am J Gastroenterol. 1988. PMID: 3163228
• [Immunologic markers of pancreatic cancer in humans].

  Kulagin PP, Chalov VV. Kulagin PP, et al. Vopr Onkol. 1983;29(8):62-7. Vopr Onkol. 1983. PMID: 6193639 Review. Russian. No abstract available.